✦ LIBER ✦

732: Heterogeneous response to bevacizumab combined with chemotherapy in patient-derived ovarian cancer xenografts

✍ Scribed by Decio, A.; Cesca, M.; Bizzaro, F.; Bani, M.R.; Giavazzi, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary ovarian cancer murine xenografts

✍ A. Ziebarth; Z. Dobbin; A. Katre; A. Steg; R. Alvarez; M. Conner; C. Landen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Emerging Role for Bevacizumab in Combina

✍ Liu, J. F.; Cannistra, S. A. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 62 KB

Prognostic factors predictive of respons

✍ A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; J. Chapman; C. McClung; T. Ki 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Prediction of response to adjuvant chemo

✍ Smith, Ross; Xue, Aiqun; Julovi, Sohel; Samra, Jaswinder; Gill, Anthony; Wong, M 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 57 KB

Maspin overexpression correlates with po

✍ Dagmara Klasa-Mazurkiewicz; Joanna Narkiewicz; Tomasz Milczek; Barbara Lipińska; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 821 KB

Immunohistochemical expression of VEGF p

✍ G. K. Siddiqui; A. B. Maclean; K. Elmasry; A. Wong te Fong; R. W. Morris; M. Ras 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 366 KB